|Bid||8.74 x 1200|
|Ask||8.77 x 3100|
|Day's Range||8.72 - 8.90|
|52 Week Range||8.24 - 13.30|
|Beta (5Y Monthly)||1.47|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Nov 27, 2017|
|1y Target Est||11.47|
In this article, we discuss the 15 best stocks to invest in today according to David Abrams based on Q2 holdings of the fund. If you want to skip our detailed analysis of Abrams’ history, investment philosophy, and hedge fund performance, go directly to the 5 Best Stocks to Invest in Today According to David […]
Teva Pharmaceutical Industries Limited (NYSE:TEVA) seems to be undervalued on a fundamental basis. However, sometimes stocks are trading below intrinsic value because there are factors external to the current money making capacity of the company. We will examine what can be the cause and the extent of the risk for investing in Teva. We will start our analysis with the balance sheet and long term debt.
Big pharma stocks appeal to many investors. Why? They often offer relative stability and solid (albeit not always spectacular) growth prospects. Many of these stocks also provide strong dividends. We asked three Motley Fool contributors to pick the smartest big pharma stocks to buy in September.